These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 7669872)
1. [Influence of glycemic blood glucose control and incipient diabetic nephropathy on the urinary excretion of N-acetyl-glucosaminidase (NAG) in diabetes mellitus]. Sánchez-Hueso MC; Mateo-Caãs J; Zamora-Madaria E An Med Interna; 1995 May; 12(5):216-20. PubMed ID: 7669872 [TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of beta-thromboglobulin and N-acetyl-beta-D-glucosaminidase in type 1 diabetes: potential indicators of early nephropathy? Patrick AW; Oliver MD; Howie AF; Dawes J; Macintyre CC; Frier BM Diabete Metab; 1990; 16(5):441-7. PubMed ID: 2150050 [TBL] [Abstract][Full Text] [Related]
3. Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats. Oktem F; Ozguner F; Yilmaz HR; Uz E; Dündar B Clin Exp Pharmacol Physiol; 2006; 33(1-2):95-101. PubMed ID: 16445706 [TBL] [Abstract][Full Text] [Related]
4. Urinary N-acetyl-beta-D-glucosaminidase activity in type I diabetes mellitus. Mungan N; Yuksel B; Bakman M; Topaloglu AK; Ozer G Indian Pediatr; 2003 May; 40(5):410-4. PubMed ID: 12768043 [TBL] [Abstract][Full Text] [Related]
5. Urinary beta 2-microglobulin levels and urinary N-acetyl-beta-D-glucosaminidase enzyme activities in early diagnosis of non-insulin-dependent diabetes mellitus nephropathy. Mocan Z; Erem C; Yildirim M; Telatar M; Değer O Diabetes Res; 1994; 26(3):101-7. PubMed ID: 7621616 [TBL] [Abstract][Full Text] [Related]
6. Urinary activities of cathepsin B, N-acetyl-beta-D-glucosaminidase, and albuminuria in patients with type 2 diabetes mellitus. Piwowar A; Knapik-Kordecka M; Fus I; Warwas M Med Sci Monit; 2006 May; 12(5):CR210-4. PubMed ID: 16641878 [TBL] [Abstract][Full Text] [Related]
7. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus. Kim NH; Kim KB; Kim DL; Kim SG; Choi KM; Baik SH; Choi DS; Kang YS; Han SY; Han KH; Ji YH; Cha DR Diabet Med; 2004 Jun; 21(6):545-51. PubMed ID: 15154937 [TBL] [Abstract][Full Text] [Related]
8. Contribution of glycemic control to the levels of urinary N-acetyl-beta-D-glucosaminidase (NAG), total protein, beta 2-microglobulin and serum NAG in type 1 (insulin-dependent) diabetes mellitus without macroalbuminuria. Watanabe Y; Nunoi K; Maki Y; Nakamura Y; Fujishima M Clin Nephrol; 1987 Nov; 28(5):227-31. PubMed ID: 3322619 [TBL] [Abstract][Full Text] [Related]
9. [Urinary glycosaminoglycans in patients with incipient diabetic nephropathy]. Ueta I; Takamatsu K; Hashimoto K Nihon Jinzo Gakkai Shi; 1995 Jan; 37(1):17-23. PubMed ID: 7699949 [TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of N-acetyl-beta-D-glucosaminidase on prediction of diabetic nephropathy]. Minakami H Hokkaido Igaku Zasshi; 1992 Mar; 67(2):234-46. PubMed ID: 1350771 [TBL] [Abstract][Full Text] [Related]
11. The significance of urinary N-acetyl-beta-D-glucosaminidase for predicting early stage diabetic nephropathy. Kato H; Takashima T; Kishikawa H; Emura S; Ohmori K Int J Clin Pract; 1997; 51(8):489-90. PubMed ID: 9536599 [TBL] [Abstract][Full Text] [Related]
12. Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics. Etherington C; Bosomworth M; Clifton I; Peckham DG; Conway SP J Cyst Fibros; 2007 Jan; 6(1):67-73. PubMed ID: 16844430 [TBL] [Abstract][Full Text] [Related]
13. Urinary excretion of n-acetyl-beta-D-glucosaminidase and retinol binding protein as alternative indicators of nephropathy in patients with type 1 diabetes mellitus. Salem MA; el-Habashy SA; Saeid OM; el-Tawil MM; Tawfik PH Pediatr Diabetes; 2002 Mar; 3(1):37-41. PubMed ID: 15016173 [TBL] [Abstract][Full Text] [Related]
14. [Urinary proteins in patients with diabetes mellitus]. Hofmann W; Guder WG Klin Wochenschr; 1989; 67 Suppl 17():37-9. PubMed ID: 2472508 [TBL] [Abstract][Full Text] [Related]
15. Infusion of radiocontrast agents induces exaggerated release of urinary endothelin in patients with impaired renal function. Fujisaki K; Kubo M; Masuda K; Tokumoto M; Hirakawa M; Ikeda H; Matsui R; Matsuo D; Fukuda K; Kanai H; Hirakata H; Iida M Clin Exp Nephrol; 2003 Dec; 7(4):279-83. PubMed ID: 14712357 [TBL] [Abstract][Full Text] [Related]
16. [Serum N-acetyl-beta-D-glucosaminidase (NAG) activity in patients with diabetes mellitus with reference to diabetic microangiopathy]. Gosiewska A; Kinalska I; Zarzycki W; Górska M; Borejszo I Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):28-30. PubMed ID: 1409037 [TBL] [Abstract][Full Text] [Related]
17. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy. Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931 [TBL] [Abstract][Full Text] [Related]
18. Blood levels of total homocysteine in patients with type 1 diabetes (with no complications, diabetic nephropathy and/or retinopathy) and in their non-diabetic relatives. Matteucci E; Rossi L; Mariani S; Fagnani F; Quilici S; Cinapri V; Giampietro O Nutr Metab Cardiovasc Dis; 2002 Aug; 12(4):184-9. PubMed ID: 12514938 [TBL] [Abstract][Full Text] [Related]
19. Uric acid excretion and dopamine-induced glomerular filtration response in patients with IgA glomerulonephritis. Sulikowska B; Manitius J; Odrowaz-Sypniewska G; Łysiak-Szydłowska W; Rutkowski B Am J Nephrol; 2008; 28(3):391-6. PubMed ID: 18063857 [TBL] [Abstract][Full Text] [Related]
20. [Determination of N-acetyl-glucosaminidase (NAG) in diabetic subjects]. Melosi A; Ricci F Quad Sclavo Diagn; 1983 Mar; 19(1):113-20. PubMed ID: 6675040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]